scispace - formally typeset
P

Peter Wipf

Researcher at University of Pittsburgh

Publications -  795
Citations -  27717

Peter Wipf is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Total synthesis & Transmetalation. The author has an hindex of 83, co-authored 767 publications receiving 25316 citations. Previous affiliations of Peter Wipf include University of California, Los Angeles & University of Vermont.

Papers
More filters
Journal ArticleDOI

Is Cdc25 a Druggable Target

TL;DR: The rationale, approaches, progress and challenges for developing small molecule inhibitors of the Cdc25 family of activating phosphatases, implicated in cancer and Alzheimer's disease are reviewed.
Journal ArticleDOI

Silver(I)-Catalyzed Addition of Zirconocenes to Epoxy Esters: A New Entry to 1,4-Dicarbonyl Compounds and Pyridazinones

TL;DR: In this article, the Ag(I)-catalyzed tandem epoxy ester rearrangement−dioxycarbenium ion addition reaction with alkenyl zirconocenes provides 1,4-keto esters that can be further converted to substituted pyridazinones.
Journal ArticleDOI

Kinetic vs. thermodynamic control in hydrozirconation reactions

TL;DR: In this article, a new method was proposed to prepare zirconocene hydrides in situ from readily available, air-stable ZIRconocene dihydride, which allowed the first time that kinetic hydrozirconation products of internal, non-functionalized alkenes can be formed in preference over isomerized, thermodynamic products.
Journal ArticleDOI

N-acetyl-L-cysteine protects astrocytes against proteotoxicity without recourse to glutathione

TL;DR: It is shown that NAC can protect astrocytes against protein misfolding stress (proteotoxicity), the hallmark of neurodegenerative disorders, and the findings suggest that the thiol group in NAC is required for its effects on glial viability and protein quality control.
Journal ArticleDOI

Total Synthesis and Biological Evaluation of Tubulysin Analogues.

TL;DR: A second-generation synthesis of the exceedingly potent antimitotic agent N14-desacetoxytubulysin H is reported as well as the preparation of nine analogues of this lead structure and C-terminal modifications that preserve the exquisite biological activity of acid 1 are discovered.